Aclarion, Inc.

ACON Healthcare Health Information Services

Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024. In the quarter to June 2026, revenue grew 30.6%, EPS grew 59.3% and free cash flow fell 41.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.85 0.10 −5.13%
Market cap
$5.6M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
5/9
Altman Z
−4.92
Beneish M
−7.47
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
64.81 32.33 89.52 84.72
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(3.76) (1.50) (2.64) (2.67)
P/B ratio
0.35 0.19 0.35 0.42
EV/Sales
(100.17) (123.47) (151.91) (107.19)
EV/EBITDA
1.01 1.37 1.42 0.95
EV/FCF
1.01 1.27 1.58 1.09
Current Ratio
17.01 14.81 19.65 16.20
Net Debt/EBITDA
6.41 6.23 6.50 5.75
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(10,293.66%) (369.78%) (276.15%) (256.94%)
Free Cash Flow Yield
(152.99%) (301.29%) (107.33%) (116.50%)
Free Cash Flow per Share
(2.06) (3.14) (1.26) (1.10)
Book value per Share
21.46 24.13 9.23 6.91
Free Cash Flow
(1.20) (1.67) (2.69) (2.70)
EV/EBIT
0.98 1.33 1.38 0.92
Other line items

Show all line items

Columns are period end dates